Epigenetic modifications and human pathologies: Cancer and CVD

Proceedings of the Nutrition Society

Volumn 70, Issue 1, 2011, Pages 47-56

  Duthie, Susan J ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Atherosclerosis; Colon Cancer; Epigenetics; Folate; Human disease; Nutrition; Polyphenols

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACETYLSALICYLIC ACID; APIGENIN; BIOCHANIN A; CURCUMIN; DAIDZEIN; DIALLYL DISULFIDE; DNA; DNA METHYLTRANSFERASE; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONOID; FOLIC ACID; FOLIC ACID DERIVATIVE; GENISTEIN; HESPERETIN; LUTEOLIN; MYRICETIN; NARINGENIN; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SELENIUM; SULFORAPHANE; TRACE ELEMENT; TUMOR SUPPRESSOR PROTEIN; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON POLYP; COLON TUMOR; CONFERENCE PAPER; DIET; DIET SUPPLEMENTATION; DNA METHYLATION; DNA REPLICATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG METABOLISM; ENZYME ACTIVITY; EPIGENETICS; FOLIC ACID DEFICIENCY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; IN VITRO STUDY; MITOSIS; NONHUMAN; PATHOPHYSIOLOGY; RISK FACTOR; RISK REDUCTION; TUMOR SUPPRESSOR GENE; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FLAVONOIDS; FOLIC ACID; HUMANS; NEOPLASMS; PHENOLS; PHYTOTHERAPY; PROTO-ONCOGENES; VITAMIN B COMPLEX;

EID: 79951769214     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665110003952     Document Type: Conference Paper

References (77)

1. Jones PA & Baylin SB (2007) The epigenomics of cancer. Cell 128, 683-692. (Pubitemid 46273572)
2. Turunen MP, Aavik E & Yla-Herttula S (2009) Epigenetics and atherosclerosis. Biochim Biophys Acta 1790, 886-891.
3. Fraga MF, Ballestar E, Paz MF et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102, 10604-10609. (Pubitemid 41061601)
4. Yen TT, Gill AM, Frigeri LG et al. (1994) Obesity, diabetes, and neoplasia in yellow Avy/- mice: ectopic expression of the agouti gene. FASEB J 8, 479-488.
5. Dolinoy DC (2008) The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev 66 (Suppl. 1), S7-S11.
6. Ross SA, Dwyer J, Umar A et al. (2008) Diet, epigenetic events and cancer prevention. Nutr Rev 66 (Suppl. 1), S1-S6.
7. Dashwood RH & Ho E (2008) Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutr Rev 66 (Suppl. 1), S36-S38.
8. Druesne-Pecollo N, Chaumontet C & Latino-Martel P (2008) Diallyl disulfide increases histone acetylation in colon cells in vitro and in vivo. Nutr Rev 66 (Suppl. 1), S39-S41.
9. Rahman I (2008) Dietary polyphenols mediated regulation of oxidative stress and chromatin remodeling in inflammation. Nutr Rev 66 (Suppl. 1), S42-S45.
10. Guil S & Esteller M (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 41, 87-95.
11. Costello JF & Plass C (2001) Methylation matters. J Med Genet 38, 285-303. (Pubitemid 32433981)
12. Gaudet F, Hodgson JG, Eden A et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300, 489-492. (Pubitemid 36444330)
13. Johnson IT & Belshaw NJ (2008) Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia. Food Chem Toxicol 46, 1346-1359. (Pubitemid 351258207)
14. Arasaradnam RP, Commane DM, Bradburn D et al. (2008) A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 3, 193-198.
15. Duthie GG, Duthie SJ & Kyle JAM (2000) Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutr Res Rev 13, 79-106. (Pubitemid 30495755)
16. Ferguson LR (2001) Role of plant polyphenols in genomic stability. Mutat Res 475, 80-111.
17. Duthie SJ (2007) Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process. Mol Nutr Food Res 51, 665-674. (Pubitemid 47083677)
18. Fang M, Chen D & Yang CS (2007) Dietary polyphenols may affect DNA methylation. J Nutr 137, 223S-228S. (Pubitemid 46052885)
19. Fang MZ, Wang Y, Hou Z et al. (2003) Tea polyphenol ( - )-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63, 7563-7570. (Pubitemid 37466673)
20. Lee WJ, Shim JY & Zhu BT (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68, 1018-1030. (Pubitemid 41345793)
21. Shukla S, Trokhan S, Resnik MI et al. (2005) Epigallocatcehin- 3-gallate causes demethylation and activation of GSTP1 gene expression in human prostate cancer LNCaP cells. Proc Am Assoc Cancer Res 46, 1572.
22. Fang MZ, Chen D, Sun Y et al. (2005) Reversal of hypermethylation and reactivation of p16INKa, RAR b and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11, 7033-7041. (Pubitemid 41428763)
23. Kato K, Long NK, Makita H et al. (2008) Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99, 647-654.
24. Chuang JC, Yoo CB, Kwan JM et al. (2005) Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-20-deoxycytidine. Mol Cancer Ther 4, 1515-1520. (Pubitemid 41556433)
25. Stressman C, Brueckner B, Musch et al. (2006) Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res 66, 2794-2800.
26. Day JK, Bauer AM, DesBordes C et al. (2002) Genistein alters methylation patterns in mice. J Nutr 132, 2419S- 2423S. (Pubitemid 34848119)
27. Morey-Kinney SR, Zhang W, Pascual M et al. (2009) Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev Res 2, 1065-1075.
28. Czeizel AE (1993) Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 306, 1645-1648. (Pubitemid 23168393)
29. Boushey CJ, Beresford SAA, Omenn GS et al. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
30. Duthie SJ, Whalley LJ, Collins AR et al. (2002) Homocysteine, B vitamin status and cognitive function in the elderly. Am J Clin Nutr 75, 908-913. (Pubitemid 34441260)
31. Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132, 2350S-2355S. (Pubitemid 34848106)
32. Sanjoaquin MA, Allen N, Couto, E et al. (2005) Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113, 825-828. (Pubitemid 40101266)
33. Kim YI (2007) Folate and colorectal cancer: an evidencebased critical review. Mol Nutr Food Res 51, 267-292.
34. McNulty H, Pentieva K, Hoey L et al. (2008) Homocysteine, B vitamins and CVD. Proc Nutr Soc 67, 232-237.
35. The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015-2022.
36. Splaver A, Lamas GA, Hennekens CH et al. (2004) Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology and the need for randomised trials. Am Heart J 148, 34-40. (Pubitemid 38906645)
37. Wierzbicki AS (2007) Homocysteine and cardiovascular disease: a review of the evidence. Diabetes Vasc Dis Res 4, 143-149. (Pubitemid 47178770)
38. The Heart Outcomes Prevention Evaluation (HOPE)2 Investigators (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. NEJM 354, 1567-1577.
39. Voutilainen S, Lakka TA, Porkkala-Sarataho E et al. (2000) Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Eur J Clin Nutr 54, 424-428. (Pubitemid 30261395)
40. Voutilainen S, Virtanen JK, Rissanen TH et al. (2004) Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 80, 317-323. (Pubitemid 41080004)
41. Doshi SN, McDowell IFW, Moat SJ et al. (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105, 22-26. (Pubitemid 34049137)
42. Usui M, Matsuoka H, Miyazaki H et al. (1999) Endothelial dysfunction by acute hyperhomocysteinemia: restoration by folic acid. Clin Sci 96, 235-239. (Pubitemid 29129174)
43. Wainfan E & Poirier LA (1992) Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 52, 2071s-2077s.
44. Pogribny IP, James SJ, Jernigan S et al. (2004) Genomic hypomethylation is specific for preneoplastic liver in folate/ methyl deficient rats and does not occur in non-target tissues. Mutat Res 548, 53-59. (Pubitemid 38446881)
45. Stempak JM, Sohn K-Y, Chiang E-P et al. (2005) Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 26, 981-990. (Pubitemid 41214328)
46. Wasson GR, McGlynn AP, McNulty H et al. (2006) Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation. J Nutr 136, 2748-2753. (Pubitemid 44771768)
47. Duthie SJ, Narayanan S, Blum S et al. (2000) Folate deficiency in vitro induces uracil misincorporation, DNA hypomethylation and inhibits DNA excision repair in immortalised normal human colon epithelial cells. Nutr Cancer 37, 127-133.
48. Duthie SJ, Mavrommatis Y, Rucklidge G et al. (2008) The response of human colonocytes to folate deficiency in vitro: functional and proteomic analysis. J Proteome Res 7, 3254-3266.
49. Balaghi M & Wagner C (1993) DNA methylation in folate deficiency: use of CpG methylase. Biochem Biophys Res Commun 193, 1184-1190. (Pubitemid 23209719)
50. Kim Y-I, Pogribny IP, Salomon RN et al. (1996) Exonspecific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine: modulation by dietary folate. Am J Clin Pathol 149, 1129-1137. (Pubitemid 26337232)
51. James SJ, Pogribny IP, Pogribna M et al. (2003) Mechanisms of DNA damage, DNA hypomethylation and tumour progression in the folate/methyl deficient rat model. J Nutr 133, 3740 S-3747 S. (Pubitemid 37406630)
52. Sohn Y-J, Stempack JM, Reid S et al. (2003) The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 24, 81-90. (Pubitemid 36193198)
53. Duthie SJ, Narayanan S, Brand GM et al. (2000) DNA stability and genomic methylation status in colonocytes isolated from methyl-donor-deficient rats. Eur J Nutr 39, 106-111. (Pubitemid 30439027)
54. Duthie SJ (2010) Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis (Epublication ahead of print; DOI 10.1007/s10545-010-9128-0).
55. Jacob RA, Gretz DM, Taylor PC et al. (1998) Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 128, 1204-1212. (Pubitemid 28317688)
56. Rampersaud GC, Kauwell GPA, Hutson AD et al. (2000) Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr 72, 998-1003.
57. Schernhammer ES, Giovannucci E, Kawasaki T et al. (2009) Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut (Epublication ahead of print, 14 October 2009).
58. Figueiredo JC, Grau MV, Wallace K et al. (2009) Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 18, 1041-1049.
59. Fenech M, Aitken C & Rinaldi J (1998) Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19, 1163-1171. (Pubitemid 28375365)
60. Ingrosso D, Cimmino A, Perna AF et al. (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinemia in patients with uremia. Blood 361, 1693-1699. (Pubitemid 36577442)
61. Pufulete M, Al-Ghnaniem R, Khushal A et al. (2005) Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 54, 648-653. (Pubitemid 40559249)
62. Cravo M, Fidalgo P, Pereira AD, et al. (1994) DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev 3, 473-479. (Pubitemid 24360815)
63. Cravo ML, Pinto AG, Chaves P et al. (1998) Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake. Clin Nutr 17, 45-49. (Pubitemid 28230839)
64. Basten GP, Duthie SJ, Pirie LP et al. (2006) Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br J Cancer 94, 1942-1947. (Pubitemid 43882589)
65. Hiltunen MO, Turunen MP, Hakkinen TP et al. (2002) DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 7, 5-11. (Pubitemid 34654067)
66. Lund G, Andersson L, Lauria M et al. (2004) DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking Apolipoprotein E. J Biol Chem 279, 29147-29154. (Pubitemid 38915787)
67. Post WS, Goldschmidt-Clermont PJ, Wilhide CC et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43, 985-991. (Pubitemid 29413198)
68. Ying AK, Hassanain HH, Roos CM et al. (2000) Methylation of the estrogen receptor-a gene promoter is selectively increased in proliferating human aoric smooth muscle cells. Cardiovasc Res 46, 172-179. (Pubitemid 30155957)
69. Hiltunen MO & Yla-Herttuala S (2003) DNA methylation, smooth muscle cells and atherogenesis. Arterioscler Thromb Vasc Biol 23, 1750-1753. (Pubitemid 37254858)
70. Chen Z, Karaplis AC, Ackerman SL et al. (2005) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity within neuropathology and aortic lipid deposition. Hum Mol Genet 10, 433-443. (Pubitemid 32181666)
71. Devlin AM, Bottiglieri T, Domann FE et al. (2005) Tissuespecific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem 27, 25506-25511. (Pubitemid 40962255)
72. Yi P, Melnyk S, Pogribna M et al. (2000) Increase in plasma homocysteine associated with parallel increase in plasma S-adenosyl homocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275, 29318-29323. (Pubitemid 32043802)
73. Brown KS, Huang Y, Lu Z-Y et al. (2006) Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells. Atherosclerosis 189, 133-141. (Pubitemid 44444913)
74. Hoffman MA, Lalla E, Lu Y et al. (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107, 675-683. (Pubitemid 32225353)
75. Zhou J, Moller J, Danielsen CC et al. (2001) Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21, 1470-1476. (Pubitemid 34219810)
76. Zhou J, Moller J, Ritskes-Hoitinga M et al. (2003) Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in ApoE-deficient mice. Atherosclerosis 168, 255-262. (Pubitemid 36703324)
77. Troen AM, Lutgens E, Smith DE et al. (2003) The atherogenic effect of excess methionine intake. Proc Natl Acad Sci USA 100, 15089-15094. (Pubitemid 37518021)